Gland Pharma Limited — Enoxaparin Exporter Profile
Indian Pharmaceutical Exporter · #1 for Enoxaparin · $58.2M export value · DGFT Verified
Gland Pharma Limited is the #1 Indian exporter of Enoxaparin with $58.2M in export value and 495 verified shipments. Gland Pharma Limited holds a 11.8% market share in Enoxaparin exports across 25 countries. The company exports 29 pharmaceutical products worth $262.0M across 15 therapeutic categories.
Gland Pharma Limited — Enoxaparin Export Profile: Buyers & Destinations
Where Does Gland Pharma Limited Export Enoxaparin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $28.1M | 606 | 55.8% |
| SAUDI ARABIA | $12.3M | 259 | 24.5% |
| PERU | $1.3M | 30 | 2.6% |
| THAILAND | $1.1M | 25 | 2.1% |
| DOMINICAN REPULIC | $939.8K | 27 | 1.9% |
| BRAZIL | $805.0K | 17 | 1.6% |
| CHILE | $749.8K | 22 | 1.5% |
| DOMINICAN REPUBLIC | $697.4K | 25 | 1.4% |
| KENYA | $645.5K | 16 | 1.3% |
| JAMAICA | $498.0K | 20 | 1.0% |
Gland Pharma Limited exports Enoxaparin to 34 countries. The largest destination is UNITED STATES accounting for 55.8% of Gland Pharma Limited's Enoxaparin shipments, followed by SAUDI ARABIA (24.5%) and PERU (2.6%). These destinations reflect Gland Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Enoxaparin from Gland Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| FRESENIUS KABI USA, LLC | UNITED STATES | $19.0M | 412 |
| BOSTON ONCOLOGY ARABIA | SAUDI ARABIA | $12.1M | 255 |
| FRESENIUS KABI USA LLC | UNITED STATES | $3.4M | 70 |
| EVERSANA | UNITED STATES | $3.2M | 70 |
| PHARMACEUTICAL TECHNOLOGY | DOMINICAN REPULIC | $1.6M | 52 |
| EVERSANA LIFE SCIENCE SERVICES LLC | UNITED STATES | $977.3K | 22 |
| FRESENIUS KABI USA LLC, | UNITED STATES | $950.0K | 19 |
| NORDIC PHARMACEUTICAL COMPANY SAC | PERU | $808.6K | 19 |
| EVERSANA EVERSANA | UNITED STATES | $589.0K | 13 |
| LABORATORIO CHILE S.A | CHILE | $525.4K | 16 |
Gland Pharma Limited supplies Enoxaparin to 71 buyers globally. The largest buyer is FRESENIUS KABI USA, LLC (UNITED STATES), followed by BOSTON ONCOLOGY ARABIA (SAUDI ARABIA) and FRESENIUS KABI USA LLC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Enoxaparin Export Value and How Much Does Gland Pharma Limited Contribute?
India exported $88.7M worth of Enoxaparin through 3,309 shipments from 223 suppliers to 118 countries, serving 505 buyers globally. Gland Pharma Limited contributes $58.2M to this total, accounting for 11.8% of India's Enoxaparin exports. Gland Pharma Limited ships Enoxaparin to 34 countries through 71 buyers.
What Is the Average Shipment Value for Gland Pharma Limited's Enoxaparin Exports?
Gland Pharma Limited's average Enoxaparin shipment value is $117.6K per consignment, based on 495 shipments totaling $58.2M. The largest destination is UNITED STATES (55.8% of Gland Pharma Limited's Enoxaparin exports).
How Does Gland Pharma Limited Compare to Other Indian Enoxaparin Exporters?
Gland Pharma Limited ranks #1 among 223 Indian Enoxaparin exporters with a 11.8% market share. The top 3 exporters are GLAND PHARMA LTD ($33.5M), GLAND PHARMA LIMITED ($24.8M), BIOLOGICAL E. LIMITED ($11.3M). Gland Pharma Limited processed 495 shipments to 25 destination countries.
What Enoxaparin Formulations Does Gland Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN | $11.5M | 237 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PREFILLED SYRINGE | $6.7M | 147 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PRE-FILLED SYRINGE | $1.9M | 42 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0.4ML PRE-FILLED SYRINGE | $1.9M | 43 |
| (LOW MOLECULAR WEIGHT HEPARIN) ENOXAPARIN SODIUM INJECTION USP, 40MG PRE-FILLEDSYRINGES | $1.8M | 40 |
| (LOW MOLECULAR WEIGHT HEPARIN) ENOXAPARIN SODIUM INJECTION USP, 40MG in 0.4ml PRE-FILLED SYRINGES | $1.7M | 43 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0 4ML PREFILLED SYRINGE | $1.6M | 31 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 30MG IN 0.3ML PREFILLED SYRINGE | $1.1M | 25 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PREFILLED SYRINGENOS | $777.4K | 18 |
| (LOW MOLECULAR WEIGHTHEPARIN) ENOXAPARINSODIUM INJECTION USP,40MG IN 0.4ML PRE-FILLEDSYRINGES | $700.0K | 14 |
Gland Pharma Limited exports 222 distinct Enoxaparin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN with 237 shipments worth $11.5M.
Regulatory Requirements: Exporting Enoxaparin to Key Markets
What Gland Pharma Limited must comply with to export Enoxaparin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Gland Pharma Limited Compare to Nearest Enoxaparin Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | GLAND PHARMA LTD | $33.5M | 669 | 25 | $50.0K |
| 1 | GLAND PHARMA LIMITED ★ | $24.8M | 495 | 25 | $50.0K |
| 3 | BIOLOGICAL E. LIMITED | $11.3M | 226 | 5 | $50.0K |
| 4 | VENUS REMEDIES LIMITED | $5.1M | 182 | 22 | $27.8K |
Gland Pharma Limited ranks #1 among 223 Indian Enoxaparin exporters. Average shipment value of $50.0K compared to the market average of $397.9K. The closest competitors by value are GLAND PHARMA LTD and BIOLOGICAL E. LIMITED.
Which Indian Ports Ship Enoxaparin Exports?
| Port | Shipments | % Share |
|---|---|---|
| HYDERABAD ICD | 555 | 16.8% |
| HYDERABAD ICD (INSNF6) | 455 | 13.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 276 | 8.3% |
| SAHAR AIR | 251 | 7.6% |
| DELHI AIR CARGO ACC (INDEL4) | 165 | 5.0% |
| DELHI AIR | 159 | 4.8% |
| NHAVA SHEVA SEA (INNSA1) | 150 | 4.5% |
| HYDERABAD AIR | 120 | 3.6% |
What Other Cardiovascular Products Does Gland Pharma Limited Export?
Gland Pharma Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Gland Pharma Limited's Enoxaparin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Gland Pharma. The Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts the profitability of exports to Europe and the U.S. East Coast, necessitating strategic adjustments in logistics and pricing strategies. (sgeexport.com)
Conversely, the India–European Union Free Trade Agreement (FTA), concluded on January 27, 2026, offers a favorable outlook. The agreement eliminates tariffs on most European optical, medical, surgical, and pharmaceutical exports to India, and vice versa, potentially enhancing Gland Pharma's competitiveness in the European market. This development aligns with the company's strategic objectives to deepen market penetration and increase market share within existing therapeutic areas. (en.wikipedia.org)
Gland Pharma Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for Gland Pharma's export operations. The company's Visakhapatnam facility's recent EIR from the USFDA underscores its commitment to quality and regulatory adherence. (business-standard.com) Additionally, the Danish Medicines Agency's Good Manufacturing Practice (GMP) compliance certification for Gland Pharma's facility further validates its manufacturing excellence. (ainvest.com)
However, challenges persist, as evidenced by the French drug regulator ANSM's issuance of ten observations to Gland Pharma's subsidiary, Cenexi, following a GMP inspection. The company is actively addressing these observations, reflecting its proactive approach to regulatory compliance and continuous improvement. (business-standard.com)
About Gland Pharma Limited
Gland Pharma Limited exports 29 products worth $262.0M. Beyond Enoxaparin, top products include Heparin, Syringe, Ketorolac, Sodium, Ondansetron. View the complete Gland Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Enoxaparin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Enoxaparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Gland Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 1,164 individual customs records matching Gland Pharma Limited exporting Enoxaparin, covering 222 formulations to 34 countries via 71 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 118+ countries, 505+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Enoxaparin Export Data from Gland Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Gland Pharma Limited's Enoxaparin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Gland Pharma Limited
Full Company Profile →
29 products · $262.0M total trade · 15 categories
Enoxaparin Stats
Company Overview
Top Products by Gland Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Gland Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Enoxaparin. For current shipment-level data, contact TransData Nexus.